Clinical Trial Research | Arkansas Children's Hospital

	•	Find a Doctor
	•	Clinical Services
	•	Inpatient Services
	•	Outpatient Services
	•	Special Services for Your Child
	•	Medical Breakthroughs
	•	The PULSE Center
	•	ECMO
	•	Research at ACH
	•	Centers for Excellence
	•	Content for Physicians
	•	Allied Health
	•	Department of Pediatrics
	•	Angel One Transport

	•	ACHRI Web Site
	•	Arkansas Children's Hospital Nutrition Center
	•	Clinical Trials Home Page
	•	About Participating in Clinical Trials
	•	Currently Enrolling Clinical Trials
	•	Sponsor/Industry Info
	•	Contact Us

How You Can Help • Events & Classes • Conferences/Courses • Web Site Feedback • Home

Pilot Study to Evaluate the Oral Absorption, Safety and Tolerability of Nepadutant Administered as a Single Dose in Infants with Colic

Indications:
Gastroenterology - Constipation/Crohns/IBS/EE

Study Description:
This study will look at the amount of study drug (Nepadutant) in the urine of infants with suspected colic after a single dose.

Eligibility Requirements:
Healthy infants ages 6-24 weeks, full term at birth (37 weeks), and be at a normal height and weight for their age. Diaper collection and diary will need to be completed at home by the child's caregiver.

Request Information for This Trial

Arkansas Children's Hospital, 1 Children�s Way, Little Rock, AR 72202-3591, (501) 364-1100 or TDD (501) 364-1184

Web Site Feedback Survey | ACH is a tobacco free campus.